Skip to content Skip to footer
Subscribe Now
Viewpoints_Andrea DiFabio
VIEWPOINTS

PharmaShots Interview: Repertoire’s Andrea DiFabio Shares Insights on the Importance of Series B Funding

In an interview with PharmaShots, Andrea DiFabio, JD, Chief Legal and Administration Officer of Repertoire Immune Medicines shares her views on the importance of $189M series B funding and how it will support the company's pipeline and manufacturing plans.Shots:The company reported the completion of a $189 million Series B financing. Founded by Flagship…
June 30, 2021

Read more

Viewpoints_Dipal Doshi
VIEWPOINTS

PharmaShots Interview: Entrada’s Dipal Doshi Shares Insights on the Series B Funding Utilize to Advance DMD Program into the Clinic

In an interview with PharmaShots, Dipal Doshi, President and Chief Executive Officer of Entrada Therapeutics share his views on $116M Series B financing and what does this milestone means for the company's pipeline.Shots:The Series B financing was led by Wellington Management Company, who was joined by Redmile Group, TCG Crossover, Greenspring Associates, Point72, Qatar Investment…
May 19, 2021

Read more

Viewpoints_Dr. Lara S. Sullivan and Dr. Ronald Herbst
VIEWPOINTS

PharmaShots Interview: Pyxis Oncology’s Dr. Lara S. Sullivan and Dr. Ronald Herbst Share Insights on the Importance of Series B Funding to Advance their Portfolio

In an interview with PharmaShots, Dr. Lara S. Sullivan, Chief Executive Officer, and Dr. Ronald Herbst, Chief Scientific Officer of Pyxis Oncology share insight on the importance of Series B funding and shed light on the company's strategy and near-term goals.Shots:Pyxis Oncology reported that it raised $152M in a series B on the heels of…
April 26, 2021

Read more

Viewpoint_Leo Grady _2020
VIEWPOINTS

PharmaShots Interview: Paige’s CEO, Leo Grady Shares Insights on its Series B Funding and the FDA’s 510(k) Clearance for FullFocus Viewer

Paige is a global digital pathology founded in 2017 by Thomas Fuchs, Dr. Sc., and colleagues from Memorial Sloan Kettering Cancer Center. The company involves computational pathology products that are targeted for patients and their care teams for effective, more informed treatment decisions. Paige has developed a platform to deliver novel technology to pathologists to…
July 17, 2020

Read more

Sign Up to Our Newsletter

Be the first to know the latest updates

[mc4wp_form id="13387" element_id="style-1"]